{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:50:16Z","timestamp":1759341016093,"version":"3.41.2"},"reference-count":214,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323910873"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["E64117000190001"],"award-info":[{"award-number":["E64117000190001"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004505","name":"Universit\u00e0 di Catania","doi-asserted-by":"publisher","award":["20722142135"],"award-info":[{"award-number":["20722142135"]}],"id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.apha.2022.02.001","type":"book-chapter","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T19:27:34Z","timestamp":1648668454000},"page":"95-139","source":"Crossref","is-referenced-by-count":3,"title":["Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.apha.2022.02.001_bb0010","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1096\/fj.201800231R","article-title":"Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice","volume":"32","author":"Abdullah","year":"2018","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2022.02.001_bb0015","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fphar.2017.00312","article-title":"Characterization and expression of sphingosine 1-phosphate receptors in human and rat heart","volume":"8","author":"Ahmed","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106487","article-title":"High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists","volume":"9","author":"Al-Jarallah","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2022.02.001_bb0025","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1182\/blood-2003-02-0460","article-title":"G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation","volume":"102","author":"Allende","year":"2003","journal-title":"Blood"},{"key":"10.1016\/bs.apha.2022.02.001_bb0030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature09128","article-title":"Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2","volume":"465","author":"Alvarez","year":"2010","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2022.02.001_bb0035","article-title":"Post-translational modifications of S1PR1 and endothelial barrier regulation","volume":"1865","author":"Anwar","year":"2020","journal-title":"Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids"},{"key":"10.1016\/bs.apha.2022.02.001_bb0040","doi-asserted-by":"crossref","first-page":"25074","DOI":"10.1074\/jbc.M801214200","article-title":"High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function","volume":"283","author":"Argraves","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0045","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1172\/JCI29877","article-title":"The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo","volume":"117","author":"Atochin","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.11.036","article-title":"Sphingosine-1-phosphate receptor 1 activity promotes tumor growth by amplifying VEGF-VEGFR2 angiogenic signaling","volume":"29","author":"Balaji Ragunathrao","year":"2019","journal-title":"Cell Reports"},{"key":"10.1016\/bs.apha.2022.02.001_bb0055","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00421-014-3080-x","article-title":"Exercise increases sphingoid base-1-phosphate levels in human blood and skeletal muscle in a time- and intensity-dependent manner","volume":"115","author":"Baranowski","year":"2015","journal-title":"European Journal of Applied Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1748-1716.2011.02322.x","article-title":"Exercise increases plasma levels of sphingoid base-1 phosphates in humans","volume":"203","author":"Baranowski","year":"2011","journal-title":"Acta Physiologica (Oxford, England)"},{"key":"10.1016\/bs.apha.2022.02.001_bb0065","doi-asserted-by":"crossref","first-page":"E398","DOI":"10.1152\/ajpendo.00134.2015","article-title":"Serum sphingolipids: Relationships to insulin sensitivity and changes with exercise in humans","volume":"309","author":"Bergman","year":"2015","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/bs.apha.2022.02.001_bb0070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00125-015-3850-y","article-title":"Muscle sphingolipids during rest and exercise: A C18:0 signature for insulin resistance in humans","volume":"59","author":"Bergman","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/bs.apha.2022.02.001_bb0075","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/sj.bjp.0703969","article-title":"Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats","volume":"132","author":"Bischoff","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nature14462","article-title":"HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation","volume":"523","author":"Blaho","year":"2015","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2022.02.001_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.annepidem.2009.01.019","article-title":"Healthy hearts--and the universal benefits of being physically active: Physical activity and health","volume":"19","author":"Blair","year":"2009","journal-title":"Annals of Epidemiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0090","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1161\/STROKEAHA.116.015371","article-title":"Selective sphingosine 1-phosphate receptor 1 agonist is protective against ischemia\/reperfusion in mice","volume":"47","author":"Brait","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/bs.apha.2022.02.001_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehp387","article-title":"Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease","volume":"31","author":"Brakch","year":"2010","journal-title":"European Heart Journal"},{"key":"10.1016\/bs.apha.2022.02.001_bb0100","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/ATVBAHA.115.307049","article-title":"Diabetes mellitus is associated with reduced high-density lipoprotein sphingosine-1-phosphate content and impaired high-density lipoprotein cardiac cell protection","volume":"36","author":"Brinck","year":"2016","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0105","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in multiple sclerosis: Therapeutic effects in the immune and the central nervous system","volume":"158","author":"Brinkmann","year":"2009","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070124","article-title":"FTY720 treatment in the convalescence period improves functional recovery and reduces reactive astrogliosis in photothrombotic stroke","volume":"8","author":"Brunkhorst","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2022.02.001_bb0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1474-4422(14)70049-3","article-title":"Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): A double-blind, randomised, placebo-controlled, phase 3 trial","volume":"13","author":"Calabresi","year":"2014","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ahj.2014.06.028","article-title":"Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications","volume":"168","author":"Camm","year":"2014","journal-title":"American Heart Journal"},{"key":"10.1016\/bs.apha.2022.02.001_bb0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/bs.apha.2022.02.001_bb0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.117.09088","article-title":"S1PR1 (Sphingosine-1-phosphate receptor 1) signaling regulates blood flow and pressure","volume":"70","author":"Cantalupo","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2022.02.001_bb0135","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.3934","article-title":"Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure","volume":"21","author":"Cantalupo","year":"2015","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apha.2022.02.001_bb0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cellsig.2018.09.019","article-title":"S1PR2 antagonist alleviates oxidative stress-enhanced brain endothelial permeability by attenuating p38 and Erk1\/2-dependent cPLA2 phosphorylation","volume":"53","author":"Cao","year":"2019","journal-title":"Cellular Signalling"},{"key":"10.1016\/bs.apha.2022.02.001_bb0145","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/01.HYP.35.6.1237","article-title":"Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo","volume":"35","author":"Cardillo","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2022.02.001_bb0150","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1091\/mbc.e09-09-0812","article-title":"Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1\/S1P3 axis","volume":"21","author":"Cencetti","year":"2010","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/bs.apha.2022.02.001_bb0155","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/s41467-021-22642-x","article-title":"Deletion of Mfsd2b impairs thrombotic functions of platelets","volume":"12","author":"Chandrakanthan","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apha.2022.02.001_bb0160","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1164\/rccm.201401-0121OC","article-title":"The sphingosine kinase 1\/sphingosine-1-phosphate pathway in pulmonary arterial hypertension","volume":"190","author":"Chen","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/bs.apha.2022.02.001_bb0165","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.119.045323","article-title":"Reduced apolipoprotein M and adverse outcomes across the spectrum of human heart failure","volume":"141","author":"Chirinos","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0170","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1096\/fj.201500064","article-title":"Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1","volume":"30","author":"Christensen","year":"2016","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2022.02.001_bb0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.celrep.2017.12.029","article-title":"The apolipoprotein M\/S1P axis controls triglyceride metabolism and brown fat activity","volume":"22","author":"Christoffersen","year":"2018","journal-title":"Cell Reports"},{"key":"10.1016\/bs.apha.2022.02.001_bb0180","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2022.02.001_bb0185","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1474-4422(19)30239-X","article-title":"Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): A multicentre, randomised, minimum 12-month, phase 3 trial","volume":"18","author":"Comi","year":"2019","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbrc.2009.08.142","article-title":"The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia","volume":"389","author":"Czech","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2022.02.001_bb0195","doi-asserted-by":"crossref","first-page":"C1367","DOI":"10.1152\/ajpcell.00246.2004","article-title":"Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue","volume":"288","author":"Danieli-Betto","year":"2005","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0200","doi-asserted-by":"crossref","first-page":"H2045","DOI":"10.1152\/ajpheart.01089.2002","article-title":"Sphingosine 1-phosphate and control of vascular tone","volume":"284","author":"Dantas","year":"2003","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.03.034","article-title":"FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing","volume":"119","author":"Das","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0210","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021261","article-title":"Endothelial Spns2 and ApoM regulation of vascular tone and hypertension via sphingosine-1-phosphate","volume":"10","author":"Del Gaudio","year":"2021","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/bs.apha.2022.02.001_bb0215","article-title":"Circulating cord blood HDL-S1P complex preserves the integrity of the feto-placental vasculature","volume":"1865","author":"Del Gaudio","year":"2020","journal-title":"Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids"},{"key":"10.1016\/bs.apha.2022.02.001_bb0220","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbadis.2018.12.022","article-title":"Sphingosine-1-phosphate promotes barrier-stabilizing effects in human microvascular endothelial cells via AMPK-dependent mechanisms","volume":"1865","author":"Dennhardt","year":"2019","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/bs.apha.2022.02.001_bb0225","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.3390\/ijms20246273","article-title":"Novel insights into the role of HDL-associated sphingosine-1-phosphate in cardiometabolic diseases","volume":"20","author":"Diarte-Anazco","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apha.2022.02.001_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2020.05.024","article-title":"Aging suppresses sphingosine-1-phosphate chaperone ApoM in circulation resulting in maladaptive organ repair","volume":"53","author":"Ding","year":"2020","journal-title":"Developmental Cell"},{"key":"10.1016\/bs.apha.2022.02.001_bb0235","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1111\/jcmm.13596","article-title":"S1PR3 is essential for phosphorylated fingolimod to protect astrocytes against oxygen-glucose deprivation-induced neuroinflammation via inhibiting TLR2\/4-NFkappaB signalling","volume":"22","author":"Dong","year":"2018","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/bs.apha.2022.02.001_bb0240","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.yjmcc.2009.10.009","article-title":"FTY720 prevents ischemia\/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1\/Akt signaling","volume":"48","author":"Egom","year":"2010","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0245","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52690","article-title":"Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta","volume":"9","author":"Engelbrecht","year":"2020","journal-title":"eLife"},{"key":"10.1016\/bs.apha.2022.02.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105819","article-title":"HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro","volume":"126","author":"Fan","year":"2020","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0255","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.1016086108","article-title":"HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells","volume":"108","author":"Feig","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2022.02.001_bb0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2016.12.009","article-title":"High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression","volume":"257","author":"Feuerborn","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.apha.2022.02.001_bb0265","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1124\/jpet.103.062828","article-title":"Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes","volume":"309","author":"Forrest","year":"2004","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2022.02.001_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052985","article-title":"The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P(1)) and hypertension (S1P(3)) in rat","volume":"7","author":"Fryer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2022.02.001_bb0275","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamaneurol.2014.1065","article-title":"Fingolimod for the treatment of intracerebral hemorrhage: A 2-arm proof-of-concept study","volume":"71","author":"Fu","year":"2014","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0280","doi-asserted-by":"crossref","first-page":"18315","DOI":"10.1073\/pnas.1416166111","article-title":"Impact of an immune modulator fingolimod on acute ischemic stroke","volume":"111","author":"Fu","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2022.02.001_bb0285","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/jphp.12214","article-title":"Sphingosine 1-phosphate increases an intracellular Ca(2+) concentration via S1P3 receptor in cultured vascular smooth muscle cells","volume":"66","author":"Fujii","year":"2014","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0290","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.devcel.2012.08.005","article-title":"The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2","volume":"23","author":"Gaengel","year":"2012","journal-title":"Developmental Cell"},{"key":"10.1016\/bs.apha.2022.02.001_bb0295","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12974-018-1323-1","article-title":"Sphingosine 1-phosphate receptor subtype 3 (S1P3) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization","volume":"15","author":"Gaire","year":"2018","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0300","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/687766","article-title":"Sphingosine-1-phosphate is involved in the occlusive arteriopathy of pulmonary arterial hypertension","volume":"6","author":"Gairhe","year":"2016","journal-title":"Pulmonary Circulation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0305","doi-asserted-by":"crossref","first-page":"ra79","DOI":"10.1126\/scisignal.aaa2581","article-title":"HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation","volume":"8","author":"Galvani","year":"2015","journal-title":"Science Signaling"},{"key":"10.1016\/bs.apha.2022.02.001_bb0310","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI12450","article-title":"Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement","volume":"108","author":"Garcia","year":"2001","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0315","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1161\/CIRCRESAHA.116.308929","article-title":"Platelet and erythrocyte sources of S1P are redundant for vascular development and homeostasis, but both rendered essential after plasma S1P depletion in anaphylactic shock","volume":"119","author":"Gazit","year":"2016","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0320","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/cvr\/cvp056","article-title":"Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts","volume":"82","author":"Gellings Lowe","year":"2009","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0325","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1476-5381.2012.02061.x","article-title":"The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate","volume":"167","author":"Gergely","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"120","key":"10.1016\/bs.apha.2022.02.001_bb0330","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1152\/japplphysiol.00345.2015","article-title":"S1P3 receptor influences key physiological properties of fast-twitch extensor digitorum longus muscle","volume":"1985","author":"Germinario","year":"2016","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0335","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1021\/acs.jmedchem.0c01109","article-title":"Bicyclic ligand-biased agonists of S1P1: Exploring side chain modifications to modulate the PK, PD, and safety profiles","volume":"64","author":"Gilmore","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0340","first-page":"4701","article-title":"Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4","volume":"24","author":"Golfier","year":"2010","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2022.02.001_bb0345","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3390\/ijms18122721","article-title":"Sphingosine-1-phosphate receptor 1, expressed in myeloid cells, slows diet-induced atherosclerosis and protects against macrophage apoptosis in Ldlr KO mice","volume":"18","author":"Gonzalez","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apha.2022.02.001_bb0350","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/HYPERTENSIONAHA.107.095349","article-title":"Candidate genes that determine response to salt in the stroke-prone spontaneously hypertensive rat: Congenic analysis","volume":"50","author":"Graham","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2022.02.001_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2018.10.027","article-title":"Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse","volume":"842","author":"Greig","year":"2019","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0360","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.clinph.2020.11.022","article-title":"Autonomic nervous system abnormalities predict cardiovascular changes after initiation of siponimod in secondary progressive multiple sclerosis","volume":"132","author":"Habek","year":"2021","journal-title":"Clinical Neurophysiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0365","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"10.1016\/bs.apha.2022.02.001_bb0370","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ki.2013.345","article-title":"Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury","volume":"85","author":"Ham","year":"2014","journal-title":"Kidney International"},{"key":"10.1016\/bs.apha.2022.02.001_bb0375","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/180705","article-title":"Sphingosine 1-phosphate distribution in human plasma: Associations with lipid profiles","volume":"2012","author":"Hammad","year":"2012","journal-title":"Journal of Lipids"},{"key":"10.1016\/bs.apha.2022.02.001_bb0380","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature12501","article-title":"Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2","volume":"502","author":"Herzog","year":"2013","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2022.02.001_bb0385","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bbalip.2008.07.003","article-title":"The vascular S1P gradient-cellular sources and biological significance","volume":"1781","author":"Hla","year":"2008","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apha.2022.02.001_bb0390","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.110.226464","article-title":"Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction","volume":"107","author":"Hoefer","year":"2010","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0395","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2008.04.024","article-title":"Angio-associated migratory cell protein and smooth muscle cell migration in development of restenosis and atherosclerosis","volume":"52","author":"Holvoet","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0400","doi-asserted-by":"crossref","first-page":"C919","DOI":"10.1152\/ajpcell.00350.2010","article-title":"S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells","volume":"300","author":"Hopson","year":"2011","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0405","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/HJH.0000000000002809","article-title":"Collecting duct-specific knockout of sphingosine-1-phosphate receptor 1 aggravates DOCA-salt hypertension in mice","volume":"39","author":"Hu","year":"2021","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.apha.2022.02.001_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138029","article-title":"Sphingosine-1-phosphate receptor-1 selective agonist enhances collateral growth and protects against subsequent stroke","volume":"10","author":"Ichijo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2022.02.001_bb0415","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbrc.2004.10.036","article-title":"Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol","volume":"325","author":"Ikeda","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2022.02.001_bb0420","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2007.03.123","article-title":"Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes","volume":"357","author":"Ito","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2022.02.001_bb0425","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.11.040","article-title":"Sphingosine-1-phosphate receptor 1 activation enhances leptomeningeal collateral development and improves outcome after stroke in mice","volume":"27","author":"Iwasawa","year":"2018","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1016\/bs.apha.2022.02.001_bb0430","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/molpharm.120.000019","article-title":"Transforming growth factor beta1 increases expression of contractile genes in human pulmonary arterial smooth muscle cells by potentiating sphingosine-1-phosphate signaling","volume":"100","author":"Ji","year":"2021","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0435","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1021\/acs.jcim.9b00642","article-title":"Molecular mechanism of S1P binding and activation of the S1P1 receptor","volume":"59","author":"Jiang","year":"2019","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/bs.apha.2022.02.001_bb0440","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.CIR.0000143632.06471.93","article-title":"Sphingosine kinase activation mediates ischemic preconditioning in murine heart","volume":"110","author":"Jin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0445","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cardiores.2007.05.029","article-title":"A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia\/reperfusion injury","volume":"76","author":"Jin","year":"2007","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0450","doi-asserted-by":"crossref","first-page":"H1970","DOI":"10.1152\/ajpheart.01029.2001","article-title":"Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts","volume":"282","author":"Jin","year":"2002","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0455","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.119.13450","article-title":"Cardiovascular effects of pharmacological targeting of sphingosine kinase 1","volume":"75","author":"Jozefczuk","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2022.02.001_bb0460","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/HYPERTENSIONAHA.120.17379","article-title":"Plasma S1P (sphingosine-1-phosphate) links to hypertension and biomarkers of inflammation and cardiovascular disease: Findings from a translational investigation","volume":"78","author":"Jujic","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2022.02.001_bb0465","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.apha.2022.02.001_bb0470","doi-asserted-by":"crossref","first-page":"106874","DOI":"10.1016\/j.vph.2021.106874","article-title":"Sphingosine 1-phosphate-induced nitric oxide production simultaneously controls endothelial barrier function and vascular tone in resistance arteries","volume":"140","author":"Kerage","year":"2021","journal-title":"Vascular Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0475","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.ATV.0000254679.42583.88","article-title":"The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"27","author":"Keul","year":"2007","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0480","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003393","article-title":"Sphingosine-1-phosphate receptor 1 regulates cardiac function by modulating Ca2+ sensitivity and Na+\/H+ exchange and mediates protection by ischemic preconditioning","volume":"5","author":"Keul","year":"2016","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/bs.apha.2022.02.001_bb0485","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1111\/bph.12678","article-title":"Lysophospholipid receptor nomenclature review: IUPHAR Review 8","volume":"171","author":"Kihara","year":"2014","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0490","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5607\/en.2016.25.5.241","article-title":"Inflammation after ischemic stroke: The role of leukocytes and glial cells","volume":"25","author":"Kim","year":"2016","journal-title":"Experimental Neurobiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0495","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1038\/ncomms8893","article-title":"Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke","volume":"6","author":"Kim","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apha.2022.02.001_bb0500","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cellsig.2005.07.011","article-title":"Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells","volume":"18","author":"Kimura","year":"2006","journal-title":"Cellular Signalling"},{"key":"10.1016\/bs.apha.2022.02.001_bb0505","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2019.02.047","article-title":"Sphigosine-1-phosphate receptor 1 promotes neointimal hyperplasia in a mouse model of carotid artery injury","volume":"511","author":"Kitano","year":"2019","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2022.02.001_bb0510","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00395-012-0294-0","article-title":"Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat","volume":"107","author":"Knapp","year":"2012","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0515","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5551\/jat.55699","article-title":"Glycation of HDL polymerizes apolipoprotein M and attenuates its capacity to bind to sphingosine 1-phosphate","volume":"28","author":"Kobayashi","year":"2021","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"10.1016\/bs.apha.2022.02.001_bb0520","doi-asserted-by":"crossref","first-page":"29367","DOI":"10.1074\/jbc.M403937200","article-title":"The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis","volume":"279","author":"Kono","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0525","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1600-6143.2005.00754.x","article-title":"The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I","volume":"5","author":"Koyrakh","year":"2005","journal-title":"American Journal of Transplantation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0530","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1161\/STROKEAHA.113.002880","article-title":"FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection","volume":"44","author":"Kraft","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/bs.apha.2022.02.001_bb0535","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrd4099","article-title":"Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond","volume":"12","author":"Kunkel","year":"2013","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.apha.2022.02.001_bb0540","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5551\/jat.RV17010","article-title":"Sphingosine 1-phosphate and atherosclerosis","volume":"25","author":"Kurano","year":"2018","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"10.1016\/bs.apha.2022.02.001_bb0545","doi-asserted-by":"crossref","first-page":"H736","DOI":"10.1152\/ajpheart.00316.2007","article-title":"Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes","volume":"294","author":"Landeen","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0550","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/neurolint12030016","article-title":"'Ozanimod to treat relapsing forms of multiple sclerosis: A comprehensive review of disease, drug efficacy and side effects","volume":"12","author":"Lassiter","year":"2020","journal-title":"Neurology International"},{"key":"10.1016\/bs.apha.2022.02.001_bb0555","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/jmcc.2002.1533","article-title":"Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection","volume":"34","author":"Lecour","year":"2002","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0560","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1194\/jlr.M070706","article-title":"S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: Calcium flux and S1PR1 internalization","volume":"58","author":"Lee","year":"2017","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0565","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1194\/jlr.M003988","article-title":"HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: The role of sphingosine-1-phosphate","volume":"51","author":"Lee","year":"2010","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0570","doi-asserted-by":"crossref","first-page":"29190","DOI":"10.1074\/jbc.M604310200","article-title":"Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity","volume":"281","author":"Lee","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0575","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2125.2012.04400.x","article-title":"Dose titration of BAF312 attenuates the initial heart rate reducing effect in healthy subjects","volume":"75","author":"Legangneux","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0580","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000153339.27064.14","article-title":"Endothelial function: Cardiac events","volume":"111","author":"Lerman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0585","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1096\/fj.201900282R","article-title":"The selective sphingosine 1-phosphate receptor 1 modulator RP101075 improves microvascular circulation after cerebrovascular thrombosis","volume":"33","author":"Li","year":"2019","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2022.02.001_bb0590","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1007\/s12035-017-0544-0","article-title":"bFGF protects against oxygen glucose deprivation\/reoxygenation-induced endothelial monolayer permeability via S1PR1-dependent mechanisms","volume":"55","author":"Lin","year":"2018","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0595","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11307-017-1141-3","article-title":"Upregulated sphingosine 1-phosphate receptor 1 expression in human and murine atherosclerotic plaques","volume":"20","author":"Liu","year":"2018","journal-title":"Molecular Imaging and Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0600","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1091\/mbc.10.4.1179","article-title":"Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1","volume":"10","author":"Liu","year":"1999","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/bs.apha.2022.02.001_bb0605","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","article-title":"Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation","volume":"106","author":"Liu","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0610","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCHEARTFAILURE.112.000123","article-title":"A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin","volume":"6","author":"Liu","year":"2013","journal-title":"Circulation. Heart Failure"},{"key":"10.1016\/bs.apha.2022.02.001_bb0615","doi-asserted-by":"crossref","first-page":"R440","DOI":"10.1152\/ajpregu.00085.2006","article-title":"Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice","volume":"292","author":"Lorenz","year":"2007","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0620","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2021.06.020","article-title":"Sphingosine 1-phosphate and its receptors in ischemia","volume":"521","author":"Lu","year":"2021","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/bs.apha.2022.02.001_bb0625","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf5325","article-title":"Endogenous agonist-bound S1PR3 structure reveals determinants of G protein-subtype bias","volume":"7","author":"Maeda","year":"2021","journal-title":"Science Advances"},{"key":"10.1016\/bs.apha.2022.02.001_bb0630","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fphar.2019.00306","article-title":"Macrophage death as a pharmacological target in atherosclerosis","volume":"10","author":"Martinet","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0635","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49405","article-title":"Apolipoprotein M-bound sphingosine-1-phosphate regulates blood-brain barrier paracellular permeability and transcytosis","volume":"8","author":"Mathiesen Janiurek","year":"2019","journal-title":"eLife"},{"key":"10.1016\/bs.apha.2022.02.001_bb0640","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cvr\/cvp086","article-title":"Sphingosine-1-phosphate receptor signalling in the heart","volume":"82","author":"Means","year":"2009","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0645","doi-asserted-by":"crossref","first-page":"11954","DOI":"10.1074\/jbc.M707422200","article-title":"S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses","volume":"283","author":"Means","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0650","doi-asserted-by":"crossref","first-page":"H2944","DOI":"10.1152\/ajpheart.01331.2006","article-title":"Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury","volume":"292","author":"Means","year":"2007","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0655","doi-asserted-by":"crossref","first-page":"17320","DOI":"10.1074\/jbc.M411674200","article-title":"Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates rac activation and adherens junction assembly in endothelial cells","volume":"280","author":"Mehta","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0660","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cvr\/cvw256","article-title":"Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension","volume":"113","author":"Meissner","year":"2017","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0665","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.4049\/jimmunol.0901586","article-title":"Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation","volume":"184","author":"Michaud","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0670","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1128\/MCB.25.24.11113-11121.2005","article-title":"Essential role for sphingosine kinases in neural and vascular development","volume":"25","author":"Mizugishi","year":"2005","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0675","doi-asserted-by":"crossref","first-page":"19672","DOI":"10.1074\/jbc.M009993200","article-title":"Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein\/phosphoinositide 3-kinase pathway in endothelial cells","volume":"276","author":"Morales-Ruiz","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0680","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvw004","article-title":"Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43","volume":"109","author":"Morel","year":"2016","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0685","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s12035-019-01844-x","article-title":"Sphingosine 1-phosphate signaling is involved in impaired blood-brain barrier function in ischemia-reperfusion injury","volume":"57","author":"Nakagawa","year":"2020","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0690","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1182\/bloodadvances.2019031948","article-title":"Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing","volume":"3","author":"Niazi","year":"2019","journal-title":"Blood Advances"},{"key":"10.1016\/bs.apha.2022.02.001_bb0695","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature06663","article-title":"Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation","volume":"452","author":"Niessen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2022.02.001_bb0700","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/CIRCULATIONAHA.106.641407","article-title":"FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"115","author":"Nofer","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0705","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","author":"Nofer","year":"2004","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0710","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","article-title":"The immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.apha.2022.02.001_bb0715","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-444-63432-0.00003-7","article-title":"The blood-brain barrier","volume":"133","author":"Obermeier","year":"2016","journal-title":"Handbook of Clinical Neurology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0720","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/intimm\/dxz037","article-title":"Sphingosine 1-phosphate and inflammation","volume":"31","author":"Obinata","year":"2019","journal-title":"International Immunology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182329","article-title":"Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6","volume":"12","author":"Ohkura","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2022.02.001_bb0730","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-511X-12-20","article-title":"Sphingosine 1-phosphate release from platelets during clot formation: Close correlation between platelet count and serum sphingosine 1-phosphate concentration","volume":"12","author":"Ono","year":"2013","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/bs.apha.2022.02.001_bb0735","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI45403","article-title":"Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice","volume":"121","author":"Oo","year":"2011","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0740","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1074\/jbc.M610318200","article-title":"Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor","volume":"282","author":"Oo","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0745","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.ATV.20.4.1013","article-title":"Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration","volume":"20","author":"Panetti","year":"2000","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0750","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.1139221","article-title":"Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate","volume":"316","author":"Pappu","year":"2007","journal-title":"Science"},{"key":"10.1016\/bs.apha.2022.02.001_bb0755","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1194\/jlr.M076927","article-title":"Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate","volume":"59","author":"Persegol","year":"2018","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0760","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000484208","article-title":"Aspirin inhibits platelet-derived sphingosine-1-phosphate induced endothelial cell migration","volume":"101","author":"Polzin","year":"2018","journal-title":"Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0765","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/ATVBAHA.113.301347","article-title":"KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-\/- mice","volume":"33","author":"Poti","year":"2013","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0770","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/cvr\/cvu136","article-title":"Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)","volume":"103","author":"Poti","year":"2014","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0775","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmed.2015.03.006","article-title":"Sphingosine 1-phosphate signaling at the blood-brain barrier","volume":"21","author":"Prager","year":"2015","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/bs.apha.2022.02.001_bb0780","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1161\/STROKEAHA.117.018505","article-title":"Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway","volume":"48","author":"Qin","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/bs.apha.2022.02.001_bb0785","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.yjmcc.2003.09.002","article-title":"Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation","volume":"35","author":"Qiu","year":"2003","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0790","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1352458515587753","article-title":"Fingolimod effects on left ventricular function in multiple sclerosis","volume":"22","author":"Racca","year":"2016","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/bs.apha.2022.02.001_bb0795","article-title":"Mechanistic regulation of SPHK1 expression and translocation by EMAP II in pulmonary smooth muscle cells","volume":"1865","author":"Ranasinghe","year":"2020","journal-title":"Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids"},{"key":"10.1016\/bs.apha.2022.02.001_bb0800","article-title":"The endothelium is both a target and a barrier of HDL's protective functions","volume":"10","author":"Robert","year":"2021","journal-title":"Cell"},{"key":"10.1016\/bs.apha.2022.02.001_bb0805","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1006\/jmcc.2001.1433","article-title":"EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes","volume":"33","author":"Robert","year":"2001","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0810","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1096\/fj.05-4647fje","article-title":"Essential requirement for sphingosine kinase activity in eNOS-dependent NO release and vasorelaxation","volume":"20","author":"Roviezzo","year":"2006","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2022.02.001_bb0815","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/ATVBAHA.116.308435","article-title":"High-density lipoprotein-associated apolipoprotein M limits endothelial inflammation by delivering sphingosine-1-phosphate to the sphingosine-1-phosphate receptor 1","volume":"37","author":"Ruiz","year":"2017","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0820","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1038\/s41598-019-44845-5","article-title":"Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke","volume":"9","author":"Salas-Perdomo","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apha.2022.02.001_bb0825","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.bjp.0707581","article-title":"Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools","volume":"153","author":"Salomone","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0830","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.phrs.2010.09.002","article-title":"Vessel-specific role of sphingosine kinase 1 in the vasoconstriction of isolated basilar arteries","volume":"62","author":"Salomone","year":"2010","journal-title":"Pharmacological Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0835","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-2999(03)01731-X","article-title":"S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate","volume":"469","author":"Salomone","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0840","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jcb.20127","article-title":"Structural and functional characteristics of S1P receptors","volume":"92","author":"Sanchez","year":"2004","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0845","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/ATVBAHA.107.143735","article-title":"Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN","volume":"27","author":"Sanchez","year":"2007","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0850","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1074\/jbc.M311743200","article-title":"Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate","volume":"279","author":"Sanna","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0855","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4331\/wjbc.v1.i11.327","article-title":"Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein","volume":"1","author":"Sato","year":"2010","journal-title":"World Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0860","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jacc.2015.07.057","article-title":"Defects of high-density lipoproteins in coronary artery disease caused by low sphingosine-1-phosphate content: Correction by sphingosine-1-phosphate-loading","volume":"66","author":"Sattler","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0865","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/bph.13476","article-title":"Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity","volume":"173","author":"Scott","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0870","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.RES.85.11.1000","article-title":"Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes","volume":"85","author":"Sekiguchi","year":"1999","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0875","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/CS20110236","article-title":"Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions","volume":"121","author":"Selim","year":"2011","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/bs.apha.2022.02.001_bb0880","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1002\/jcp.30193","article-title":"Activation of yes-associated protein mediates sphingosine-1-phosphate-induced proliferation and migration of pulmonary artery smooth muscle cells and its potential mechanisms","volume":"236","author":"Shi","year":"2021","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0885","doi-asserted-by":"crossref","first-page":"44131","DOI":"10.1038\/srep44131","article-title":"Vascular transcriptome profiling identifies Sphingosine kinase 1 as a modulator of angiotensin II-induced vascular dysfunction","volume":"7","author":"Siedlinski","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apha.2022.02.001_bb0890","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/ATVBAHA.110.213496","article-title":"Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis","volume":"31","author":"Skoura","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0895","article-title":"Decreased astrocytic CCL2 accounts for BAF-312 effect on PBMCs transendothelial migration through a blood brain barrier in vitro model","author":"Spampinato","year":"2021","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114465","article-title":"Protective effect of the sphingosine-1 phosphate receptor agonist siponimod on disrupted blood brain barrier function","volume":"186","author":"Spampinato","year":"2021","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133392","article-title":"Sphingosine 1 phosphate at the blood brain barrier: Can the modulation of S1P receptor 1 influence the response of endothelial cells and astrocytes to inflammatory stimuli?","volume":"10","author":"Spampinato","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2022.02.001_bb0910","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0271678X15617172","article-title":"Molecular pathophysiology of cerebral edema","volume":"36","author":"Stokum","year":"2016","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/bs.apha.2022.02.001_bb0915","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1165\/rcmb.2012-0048OC","article-title":"Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury","volume":"47","author":"Sun","year":"2012","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/bs.apha.2022.02.001_bb0920","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal2722","article-title":"An engineered S1P chaperone attenuates hypertension and ischemic injury","volume":"10","author":"Swendeman","year":"2017","journal-title":"Science Signaling"},{"key":"10.1016\/bs.apha.2022.02.001_bb0925","first-page":"E1614","article-title":"CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction","volume":"112","author":"Tabeling","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2022.02.001_bb0930","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbalip.2004.01.006","article-title":"Sphingosine-1-phosphate receptors: Receptor specificity versus functional redundancy","volume":"1682","author":"Taha","year":"2004","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apha.2022.02.001_bb0935","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/cvr\/cvn118","article-title":"G12\/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase","volume":"79","author":"Takashima","year":"2008","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0940","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4331\/wjbc.v1.i10.298","article-title":"Roles of sphingosine-1-phosphate signaling in angiogenesis","volume":"1","author":"Takuwa","year":"2010","journal-title":"World Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb0945","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp312","article-title":"S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species","volume":"85","author":"Takuwa","year":"2010","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0950","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbalip.2008.04.003","article-title":"Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system","volume":"1781","author":"Takuwa","year":"2008","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apha.2022.02.001_bb0955","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","article-title":"High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor","volume":"114","author":"Theilmeier","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0960","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1538-7836.2011.04194.x","article-title":"Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation","volume":"9","author":"Ulrych","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/bs.apha.2022.02.001_bb0965","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCRESAHA.115.306901","article-title":"Sphingosine 1-phosphate produced by sphingosine kinase 2 intrinsically controls platelet aggregation in vitro and in vivo","volume":"117","author":"Urtz","year":"2015","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0970","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCRESAHA.107.165845","article-title":"Vascular endothelium as a contributor of plasma sphingosine 1-phosphate","volume":"102","author":"Venkataraman","year":"2008","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb0975","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature24053","article-title":"Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets","volume":"550","author":"Vu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2022.02.001_bb0980","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1358\/dnp.2004.17.6.829028","article-title":"Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors","volume":"17","author":"Waeber","year":"2004","journal-title":"Drug News & Perspectives"},{"key":"10.1016\/bs.apha.2022.02.001_bb0985","article-title":"Opposing roles of S1P3 receptors in myocardial function","volume":"9","author":"Wafa","year":"2020","journal-title":"Cell"},{"key":"10.1016\/bs.apha.2022.02.001_bb0990","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018816977","article-title":"SphK1\/S1P mediates TGF-beta1-induced proliferation of pulmonary artery smooth muscle cells and its potential mechanisms","volume":"9","author":"Wang","year":"2019","journal-title":"Pulmonary Circulation"},{"key":"10.1016\/bs.apha.2022.02.001_bb0995","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.2174\/0929867326666190308133732","article-title":"FTY720 (fingolimod) ameliorates brain injury through multiple mechanisms and is a strong candidate for stroke treatment","volume":"27","author":"Wang","year":"2020","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100599","article-title":"S1P induces proliferation of pulmonary artery smooth muscle cells by promoting YAP-induced Notch3 expression and activation","volume":"296","author":"Wang","year":"2021","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb1005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.22186","article-title":"Fingolimod provides long-term protection in rodent models of cerebral ischemia","volume":"69","author":"Wei","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.apha.2022.02.001_bb1010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.RES.0000244088.33375.52","article-title":"Sphingosine-1 phosphate prevents monocyte\/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor","volume":"99","author":"Whetzel","year":"2006","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb1015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm1666","article-title":"G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension","volume":"14","author":"Wirth","year":"2008","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apha.2022.02.001_bb1020","first-page":"85","article-title":"S1P control of endothelial integrity","volume":"378","author":"Xiong","year":"2014","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"10.1016\/bs.apha.2022.02.001_bb1025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/cns.13626","article-title":"Sphingosine-1-phosphate receptor 3 is implicated in BBB injury via the CCL2-CCR2 axis following acute intracerebral hemorrhage","volume":"27","author":"Xu","year":"2021","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/bs.apha.2022.02.001_bb1030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12931-020-01553-3","article-title":"The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation and puncture (CLP) in mice","volume":"21","author":"Yang","year":"2020","journal-title":"Respiratory Research"},{"key":"10.1016\/bs.apha.2022.02.001_bb1035","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/oxfordjournals.jbchem.a021681","article-title":"Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum","volume":"121","author":"Yatomi","year":"1997","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb1040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood.V86.1.193.bloodjournal861193","article-title":"Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets","volume":"86","author":"Yatomi","year":"1995","journal-title":"Blood"},{"key":"10.1016\/bs.apha.2022.02.001_bb1045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/89986","article-title":"High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase","volume":"7","author":"Yuhanna","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apha.2022.02.001_bb1050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.prostaglandins.2013.06.001","article-title":"Sphingosine-1-phosphate receptor-2 mediated NFkappaB activation contributes to tumor necrosis factor-alpha induced VCAM-1 and ICAM-1 expression in endothelial cells","volume":"106","author":"Zhang","year":"2013","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2022.02.001_bb1055","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/jnc.15457","article-title":"Ponesimod protects against neuronal death by suppressing the activation of A1 astrocytes in early brain injury after experimental subarachnoid hemorrhage","volume":"158","author":"Zhang","year":"2021","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.apha.2022.02.001_bb1060","doi-asserted-by":"crossref","first-page":"H3150","DOI":"10.1152\/ajpheart.00587.2006","article-title":"Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia","volume":"293","author":"Zhang","year":"2007","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb1065","doi-asserted-by":"crossref","first-page":"H250","DOI":"10.1152\/ajpheart.00372.2015","article-title":"Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction","volume":"310","author":"Zhang","year":"2016","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2022.02.001_bb1070","article-title":"A biochemical approach to understand the pathogenesis of advanced pulmonary arterial hypertension: Metabolomic profiles of arginine, sphingosine-1-phosphate, and heme of human lung","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2022.02.001_bb1075","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.016371","article-title":"Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: A pilot trial","volume":"132","author":"Zhu","year":"2015","journal-title":"Circulation"}],"container-title":["Advances in Pharmacology","New Targets for the Treatment of Hypertension and Associated Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358922000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358922000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:22:22Z","timestamp":1753338142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358922000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323910873"],"references-count":214,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2022.02.001","relation":{},"ISSN":["1054-3589"],"issn-type":[{"type":"print","value":"1054-3589"}],"subject":[],"published":{"date-parts":[[2022]]}}}